Skip to main content
Premium Trial:

Request an Annual Quote

Ecopia BioSciences Microbe Gene Scanning Technology Gets Initial Patent Nod

NEW YORK, Jan. 24 - Ecopia BioSciences said today that its genome scanning technology was recognized by the Canadian Patent Office as "novel and inventive."

 

In addition to the Notice of Allowance issued by the patent office, Ecopia said it has patents pending in the USand other countries.

 

The Montreal-based company's high throughput gene clustering discovery method begins by sequencing short segments of DNA called gene sequence tags, which are then compared to the company's database of microbial gene clusters involved in biosynthesis, according to the company. After a GST is matched to a gene cluster from the database, researchers identify genes next to the GST and assemble the target gene cluster.

 

Ecopia said it is using the technology to hunt for antibacterial, antifungal, and anticancer agents.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.